Sintetica SA   Report issue

For profit Phase 2 Phase 3
Founded: Mendrisio Switzerland (1921)

Organization Overview

First Clinical Trial
2013
NCT02067806
First Marketed Drug
2019
phenylephrine (Prefrin)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Sintetica SA | SINTETICA SA | SINTETICA, SA | Vissum Alicante, Calle del Cabañal 1, 03016 Alicante, Spain